At a glance
Also known as
Apo B; Lipoprotein B; LPB; Apolipoprotein B-100
Why get tested?
Apolipoprotein B (Apo B) is used to help evaluate your risk of developing heart disease
When to get tested?
When you have a personal or family history of heart disease and/or and your doctor is trying to determine your risk of developing cardiovascular disease (CVD). It is sometimes measured to help monitor treatment for hyperlipidaemia to help diagnose a rare Apo B deficiency o to assist in circumstances where standard cholestrol tests are less accurate.
A blood sample drawn from a vein in your arm
Note: This test is often ordered at the same time as other tests that require fasting, such as a LDL-C (LDL-Cholesterol), HDL-C (HDL-Cholesterol) and triglycerides; therefore, you may be instructed to fast for 8-12 hours prior to having this test.
What is being tested?
There are actually two forms fo apolipoprotein B: Apo B-100 and Apo B-48. ApoB-48 is created in the intestines. It is an integral part of the structure of chylomicrons, large lipoproteins that are responsible for the intial transport of dietary lipids. Laboratory tests typically do not measure ApoB- 48 and only measure ApoB-100, which is often abbreviated to Apo B or apolipoprotein B.
Apo B-100 is a that is an essential part of the very low density lipoprotein (VLDL) and low density lipoprotein (LDL) complexes. Apolipoprotein B helps provide structural integrity to complexes and directs transport of the water-insoluble lipids (like cholesterol and triglycerides) in blood. Apo B is recognised by LDL receptors found on the surface of many of the body's cells. These receptors promote the uptake of cholesterol into the cells.
In the liver, the body packages lipids and combines them with Apo B-100 (made in the liver) to form triglyceride-rich VLDL. Lipoprotein lipase (LPL) is an mainly produced by adipose (fat) tissue and muscle but other tissues as well. LPL removes triglycerides from VLDL to create first, intermediate density lipoproteins (IDL) and then, low density lipoproteins (LDL - the "bad" cholesterol).
Whilst VLDL and LDL particles contain a variable amount of cholestrol, each particle contains exactly one APo B100 particle , making it a superior measure of the number of non-HDL particles than non-HDL cholestrol.
The cholesterol that LDL and Apo B-100 transport is vital for cell membrane integrity, sex hormone production, and steroid production. In excess, however, LDL can lead to fatty deposits () in artery walls and lead to hardening and scarring of the blood vessels. This narrows the coronary vessels that supply the heart (coronary artery disease or CAD) and increases the risk of heart attack. The LDL cholesterol (LDL-C) test is routinely ordered as part of a lipid profile. It is usually calculated from the total cholesterol level and tends to be less reliable as triglyceride levels rise. Some labs will directly measure LDL-C levels.
Apo B-100 levels tend to mirror LDL-C levels however, in some conditions such as Lipoprotein X, the ApoB-100 and LDL-C levels are discordant. In Lipoprotein X, routine cholestrol testing may approximate and monitor the LDL level.
Some scientists think that Apo B-100 levels may eventually prove to be a better indicator of risk of atherosclerotic heart disease than LDL-C however further studies are needed at present.
How is the sample collected for testing?
A blood sample is obtained by inserting a needle into a vein in the arm.
Is any test preparation needed to ensure the quality of the sample?
There is no special preparation needed for an apolipoprotein B-100 test. However, this test is often ordered at the same time as other tests that do require fasting, such as a LDL-C, HDL-C and triglycerides. Therefore, the patient is often instructed to fast for 12 hours prior to having this test.
How is it used?
Apo B-100 levels are used, along with other lipid tests, to help determine an individual's risk of developing heart disease. It is not used as a general population screen but may be ordered when a patient has a family history of heart disease and/or . It may be performed, along with other tests, to help diagnose the cause of hyperlipidaemia, especially when someone has elevated triglyceride levels (preventing accurate LDL cholesterol calculations).
Sometimes doctors will order both Apo A (associated with high-density lipoprotein (HDL) - the 'good' cholesterol) and Apo B-100 levels to get a ratio of Apo B/Apo A to obtain additional risk information.
Occasionally Apo B-100 levels may be ordered to monitor the effectiveness of lipid treatment. In rare cases, they may be measured to help diagnose a genetic problem that causes over- or under-production of Apo B-100.
When is it requested?
Apo B-100 may be measured, along with other lipid tests, when your doctor is trying to evaluate your risk of developing atherosclerotic heart disease and when you have a personal or family history of heart disease and/or hyperlipidaemia, especially when you have significantly elevated triglyceride levels. Sometimes Apo B-100 is monitored when you are undergoing treatment for hyperlipidaemia. Apo B-100 is also sometimes ordered in conditions such as Lipoprotein X where the cholestrol values on routine testing are thought to be falsely elevated.
What does the test result mean?
Elevated levels of Apo B-100 correspond to elevated levels of LDL-C and are associated with an increased risk of CAD. Elevations may be due to a high fat diet and/or decreased clearing of LDL from the blood. Increased levels of Apo B-100 are seen with hyperlipidaemia and in those patients with:
- Familial hypercholesterolaemia
- Familial combined hyperlipidaemia (an inherited disorder causing high blood levels of cholesterol and triglycerides)
- Nephrotic syndrome (a kidney disease)
- Pregnancy (levels increase temporarily and decrease again after delivery)
Apo B-100 levels may be decreased with any condition that affects lipoprotein production or affects its synthesis and packaging in the liver. Lower levels are seen with:
- Drugs such as: oestrogen ( in post-menopausal women), lovastatin, simvastatin, niacin, and thyroxine
- Diet: Vegans have lower levels of Apo B-100 than meat eaters
- Weight reduction
- Severe illness
- Familial hypobetalipoproteinaemia and abetalipoproteinaemia
A high ratio of Apo B-100/Apo A may indicate a higher risk of developing coronary artery disease.
Is there anything else I should know?
Some elevations of Apo B-100 (and LDL-C) are due to mutations in the Apo B gene that cause it to produce Apo B-100 that is not recognised as easily by LDL receptors and thus blood cholestrol levels become elevated. This is one of the causes of a condition caused familial hypercholesterolaemia. More commonly in familail hypercholesterolaemia, the fault lies with a mutation of the LDL receptor gene. This slows the clearing of LDL from the blood and increases the risk of heart disease.
Should my doctor be measuring Apo B-48?
While researchers are looking into the role of chylomicrons (the lipoprotein that contains Apo B-48), there is currently no reason to measure Apo B-48.
What can I do to lower my Apo B-100?
Improving your diet and taking more exercise can lower LDL
levels (and increase HDL
- the good cholesterol). This will lower your Apo B-100 levels and decrease your risk of heart disease.
Related lab tests
LDL, Lipids, Cholesterol, Apolipoprotein A-I, HDL, Lipoprotein (a), hsCRP, Homocysteine
More on this site
Conditions: Heart attack, stroke, congestive heart failure, angina, CVD
Elsewhere on the web
RCPA Manual: Apolipoprotein
Genetics Home Reference - Apo B
Patient (UK) - Apolipoproteins
Yuan Li, Ping-Ping He, Da-Wei Zhang, Xi-Long Zheng, Fracisco S. Cayabyab,Wei-Dong Yin, Chao-Ke Tang. Lipoprotein lipase: From gene to atherosclerosis. Atherosclerosis 237 (2014) 597-608
Raaj R. Sankatsing, Sigrid W. Fouchier, Stefan de Haan, Barbara A. Hutten, Eric de Groot, John J.P. Kastelein, Erik S.G. Stroes Hepatic and Cardiovascular Consequences of Familial Hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol. 2005;25:1979-1984
Pierre N.M. Demacker, Mario J. Veerkamp, Sebastian J.H. Bredie, Santica M. Marcovina, Jacqueline de Graaf, Anton F.H. Stalenhoef. Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia. Atherosclerosis 153 (2000) 483–490
Marleen M.J. van Greevenbroek, Anton F.H. Stalenhoef, Jacqueline de Graaf, Martijn C.G.J. Brouwersa. Familial combined hyperlipidemia: from molecular insights to tailored therapy. Curr Opin Lipidol 2014, 25:176–182
Ariel Brautbar, Emili Leary, Kristen Rasmussen, Don P. Wilson, Robert D. Steiner, Salim Virani. Genetics of Familial Hypercholesterolemia. Curr Atheroscler Rep (2015) 17: 20
Bhavin B. Adhyaru, Terry A. Jacobson. New Cholesterol Guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk A Comparison of the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines with the 2014 National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia. Cardiol Clin 33 (2015) 181–196
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. Journal of the American College of Cardiology Vol. 63, No. 25, 2014
Last Review Date: June 15, 2022
Was this page helpful?